Instructor, Medicine, University of Washington School of Medicine

Infectious Disease

Joshua T. Schiffer, MD works in the field of Infectious Disease. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Joshua Schiffer is also a published physician. He has 35 paper published. The most recent paper is: The management of epidural haematomas--surgical versus conservative treatment. He accepts all Medicare patients.

Publications

---

• Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants.
• Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.
• Safety and efficacy of combination antiretroviral therapy in HIV-infected adults undergoing autologous or allogeneic hematopoietic cell transplant for hematologic mali...
• Plasma and Cerebrospinal Fluid Herpes Simplex Virus Levels at Diagnosis and Outcome of Neonatal Infection.
• Herpes Simplex Virus-2 Genital Tract Shedding Is Not Predictable over Months or Years in Infected Persons.
• The majority of CD4+ T-cell depletion during acute SHIV89.6P infection occurs in uninfected cells.
• Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current Herpes Simplex Virus-2 directed antiviral agents.
• Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach.
• CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.
• Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.
• Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
• Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
• The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.
• A siege of hepatitis: fighting a defiant virus.
• Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
• Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.
• Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.
• New concepts in understanding genital herpes.
• With jaundiced eyes.
• Multisystem mystery.
• Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis.
• Cases from the Osler Medical Service at Johns Hopkins University. Sister Mary Joseph nodule.
• Rotavirus infection and epidermal necrolysis of the bowel in a patient with AIDS.
• HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.
• Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.
• Feverish, jaundiced.
• Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis.
• The management of epidural haematomas--surgical versus conservative treatment.
• Polysomnography in patients with intracranial tumors before and after operation.
• Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.
• Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.
• AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication.
• Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection.
• Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding.

Schools

---

• Johns Hopkins Univ Sch Of Med

• Johns Hopkins Hospital

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Education

---

• University of Washington
• Johns Hopkins University
• Johns Hopkins University School of Medicine

Drug Facts

---

NPI NUMBER		1639114929
NPPES Provider LastName		SCHIFFER
NPPES Provider FirstName		JOSHUA
NPPES Provider ZIPCode		981950001
NPPES Provider State		WA
Specialty Description		Infectious Disease
Total Claim Count		733.0
Distinct Opioid Count		4.0
Opioid Claim Count		70.0
Percent Opioid Claims		9.55

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1639114929
Last Name Of The Provider	SCHIFFER
First Name Of The Provider	JOSHUA
View All

Similar Doctors

---

	Dr. Aley G. Kalapila, MD This Doctor is OpenDoctor Recommended.
	Dr. Marcel E. Curlin, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas R. Hawn, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Chia C. Wang, MD This Doctor is OpenDoctor Recommended.
	Dr. Gregory B. Moss, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven A. Pergam, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert D. Harrington Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Warren T. Phipps, MD This Doctor is OpenDoctor Recommended.
	Dr. Carey Farquhar, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Julia C. Dombrowski, MD This Doctor is OpenDoctor Recommended.
	Dr. Raymond S. McClelland, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog